Healthcare & Pharmaceutical Management

Healthcare Board Governance and Clinical Quality Oversight

Gain the frameworks to strengthen board-level clinical governance: quality dashboards, risk registers, sentinel event escalation and regulatory inspection readiness for hospital and health system boards.

Duration5 training days
Content4 modules · 8 sessions
On completionAccredited attendance certificate
About the programme

Course Overview

Health system boards are increasingly held to account for clinical outcomes, not only financial performance, yet many non-executive directors still receive quality papers they lack the structure to interrogate. This course addresses that gap directly: it builds the governance architecture, from ward-level reporting through sub-committees to full board decision, that lets directors ask the right question at the right tier rather than drowning in metrics. Participants work through real governance failures to understand where board oversight, rather than frontline care, was the point of breakdown, and they leave with templates for board assurance frameworks, risk appetite statements and sentinel event escalation pathways. The course also covers regulatory inspection readiness, non-executive recruitment and board self-assessment, so directors can evaluate their own effectiveness as rigorously as they evaluate clinical performance. Case discussions draw on maternity safety, infection control and capacity crises to keep the material grounded in decisions boards actually face.

Expected Learning Outcomes

01

Design a multi-tier clinical quality committee structure with clear terms of reference and escalation triggers.

02

Build a board assurance framework and single-page quality dashboard linking objectives, controls and residual risk.

03

Apply sentinel event classification to determine which incidents require immediate board-level notification.

04

Draft a board risk appetite statement and maintain an enterprise risk register aligned to ISO 31000:2018.

05

Prepare a board for an accreditation survey or regulatory inspection using self-assessment and mock review techniques.

06

Evaluate non-executive director skills mix and design an induction programme grounded in direct clinical exposure.

07

Run a board effectiveness review that tests challenge culture, decision quality and follow-through on quality actions.

Who Should Attend

01

Non-executive and executive directors serving on hospital or health system boards.

02

Chief nursing officers and medical directors preparing board-level quality reports.

03

Board secretaries and governance leads managing committee structures and papers.

04

Quality and patient safety directors reporting serious incidents to the board.

05

Trust chairs and audit committee chairs overseeing risk and regulatory compliance.

06

Senior regulatory affairs and compliance managers coordinating accreditation surveys.

Course Modules

Select any module to see its sessions and points.

01

Board Structures and Committee Architecture for Quality Oversight

2 sessions · 8 points

Session 1Designing Board and Sub-Committee Structures for Clinical Quality

  • Map the quality committee structure from ward level to board level, defining terms of reference, escalation triggers and reporting frequency for each tier.
  • Distinguish the fiduciary duties of executive and non-executive directors from their specific duty of quality oversight under corporate and healthcare governance codes.
  • Draft a committee terms-of-reference template that specifies membership, quorum, voting rights and the matters reserved for full board decision.
  • Build a reporting calendar that sequences quality, finance, workforce and risk papers so the board reviews clinical outcomes with equal weight to financial performance.

Session 2Legal Duties, Liability and the Duty of Candour

  • Analyse case examples of board liability following adverse clinical outcomes to identify where oversight, not clinical care itself, was found deficient.
  • Apply duty-of-candour and open-disclosure obligations to draft a board policy on when and how patients and families are informed of harm.
  • Distinguish corporate manslaughter exposure from individual director liability and assign named board leads for safety, workforce and infection prevention.
  • Review Director and Officer insurance coverage against the organisation's clinical risk profile and identify gaps a quality-related claim could expose.
02

Quality Assurance Systems and Incident Escalation to the Board

2 sessions · 8 points

Session 1Board Assurance Frameworks and Quality Dashboards

  • Construct a board assurance framework that links strategic quality objectives to the controls, gaps and actions the board must track each quarter.
  • Design a single-page quality dashboard combining mortality ratios, infection rates, complaint themes and staffing metrics with red-amber-green thresholds.
  • Set escalation thresholds that automatically route a metric breach from ward manager to executive team to board committee within a defined timeframe.
  • Triangulate soft intelligence such as complaints, staff surveys and whistleblowing reports against hard quality metrics to surface emerging risks early.

Session 2Serious Incident and Sentinel Event Reporting to the Board

  • Apply a sentinel event policy to classify incidents by severity and determine which cases require immediate board notification versus routine reporting.
  • Facilitate a board-level review of a root-cause analysis, questioning whether identified actions address system causes rather than individual blame.
  • Track the closure of safety action plans through a board sub-committee, verifying evidence of implementation rather than accepting self-reported completion.
  • Benchmark serious incident rates and themes against peer organisations to test whether the board's risk appetite for clinical harm is appropriately calibrated.
03

Risk Registers, Regulatory Readiness and Accreditation Surveys

2 sessions · 8 points

Session 1Enterprise Risk Registers and Risk Appetite Statements

  • Draft a board-level risk appetite statement for clinical, financial and reputational risk that sets tolerance thresholds for each risk category.
  • Maintain an enterprise risk register aligned to ISO 31000:2018 that links each clinical risk to its owner, mitigating controls and residual rating.
  • Stress-test the risk register against a simulated capacity crisis to check whether mitigations remain credible under sustained operational pressure.
  • Review deep-dive risk reports on high-severity items such as maternity safety or sepsis recognition with the relevant clinical director present.

Session 2Accreditation Surveys and Regulatory Inspection Preparedness

  • Prepare a board-level self-assessment against the applicable accreditation standard ahead of a scheduled or unannounced regulatory inspection.
  • Assign board members to shadow inspectors during a mock survey to identify documentation gaps and inconsistent staff responses before the real visit.
  • Review the organisation's improvement plan following a previous inspection finding and confirm evidence of sustained, not temporary, corrective action.
  • Coordinate the board's public response and media statement following a critical regulatory report without minimising the findings it must act on.
04

Board Effectiveness, Composition and Continuous Improvement

2 sessions · 8 points

Session 1Non-Executive Director Recruitment and Board Skills Mix

  • Conduct a skills-gap analysis of the current board to identify missing clinical, digital or financial expertise before the next recruitment round.
  • Design a non-executive director interview process that tests candidates' willingness to challenge executive quality assurances, not just their credentials.
  • Structure an induction programme for new board members that includes ward visits, patient story sessions and shadowing of a quality committee.
  • Evaluate the balance of clinical and non-clinical backgrounds on the board against the complexity of the services the organisation provides.

Session 2Board Self-Assessment and Continuous Quality Improvement Cycles

  • Run an annual board effectiveness review using external facilitation to assess decision quality, challenge culture and papers' clarity.
  • Compare board meeting minutes against actual outcomes to test whether agreed quality actions were implemented within the committed timescale.
  • Facilitate a board development session using de-identified case studies of governance failure to rehearse how the board would respond.
  • Set measurable improvement targets for board practice itself, such as reduced paper volume, sharper questioning and faster escalation response times.

What the participant receives

4 course modules

A structured syllabus

8 training sessions

across 5 days

32 detailed points

Applied, detailed content

Accredited attendance certificate

On completing the programme

Complete your registration

We will contact you within one business day to confirm.

Ready to start?

Reserve your seat and start building the skill.

Enroll now

Share this course